Characteristics | 1 Type lesion n = 39 | 2 Type lesions n = 40 | 3 Type lesions n = 53 | p-value |
---|---|---|---|---|
Age (years)-median (IQR) | 27.93 (22.75–31.92) | 28.10 (22.04–49.06) | 37.92 (24.58–47.64) | 0.07 |
Sex | 0.94 | |||
Male | 23 (59.0) | 25 (62.5) | 33 (62.3) | |
Female | 16 (41.0) | 15 (37.5) | 20 (37.7) | |
Education | 0.12 | |||
Elementary and secondary school | 25 (64.1) | 29 (72.5) | 44 (83.0) | |
Higher education | 14 (35.9) | 11 (27.5) | 9 (17.0) | |
Prior TB | 1 (2.6) | 3 (7.5) | 12 (22.6) | < 0.01 |
BCG vaccination | 35 (89.7) | 39 (97.5) | 48 (92.3) | 0.38 |
Smoking | 7 (17.9) | 13 (32.5) | 8 (15.4) | 0.12 |
Smoker at home | 5 (12.8) | 1 (2.5) | 5 (9.6) | 0.24 |
Cannabis use | 6 (15.4) | 8 (20.0) | 6 (11.5) | 0.54 |
Illicit drug use | 3 (7.7) | 7 (17.5) | 6 (11.5) | 0.41 |
Alcohol use | 21 (53.8) | 23 (57.5) | 23 (44.2) | 0.42 |
Hypertension | 1 (2.6) | 3 (7.5) | 3 (5.8) | 0.61 |
Asthma | 4 (10.3) | 1 (2.5) | 2 (3.8) | 0.26 |
Renal disease | 0 (0.0) | 1 (2.5) | 1 (1.9) | 0.64 |
Slow scarring | 6 (15.4) | 5 (12.5) | 8 (15.4) | 0.91 |
Metformin use | 0 (0.0) | 2 (5.3) | 5 (9.8) | 0.13 |
BMI (kg/m2)-median (IQR) | 23.53 (21.22–25.08) | 22.28 (20.08–25.39) | 22.66 (20.19–25.68) | 0.28 |
Waist circumference (cm) -median (IQR) | 84 (76–90) | 81 (75–86) | 82 (77–89) | 0.34 |
Hemoglobin (g/dL) -median (IQR) | 12.60 (11.50–13.30) | 12.15 (10.85–13.53) | 11.25 (10.53–12.65) | 0.03 |
FPG (mg /dL) -median (IQR) | 91.5 (7.3) | 100.4 (36.3) | 140.9 (91.7) | < 0.01 |
HbA1c (%)- median (IQR) | 4.9 (0.41) | 5.2 (0.8) | 6.9 (3.2) | < 0.01 |
OGTT (mg/dL) -median (IQR) | 113.4 (29.9) | 109.8 (26.7) | 115.0 (28.6) | 0.76 |
AFB smear | 0.04 | |||
Negative | 23 (59.0) | 17 (43.6) | 17 (32.1) | |
1+ | 8 (20.5) | 7 (17.9) | 12 (22.6) | |
2+ | 1 (2.6) | 6 (15.4) | 7 (13.2) | |
3+ | 6 (15.4) | 7 (17.9) | 15 (28.3) | |
Scanty | 1 (2.6) | 2 (5.1) | 2 (3.8) | |
L-J culture | < 0.01 | |||
Negative | 14 (36.8) | 16 (43.2) | 6 (11.5) | |
1+ | 18 (47.4) | 14 (37.8) | 29 (55.8) | |
2+ | 1 (2.6) | 4 (10.8) | 4 (7.7) | |
3+ | 1 (2.6) | 2 (5.4) | 4 (7.7) | |
Colonies | 4 (10.5) | 1 (2.7) | 9 (17.3) | |
BD MGIT™ 960 System | 0.43 | |||
Positive | 18 (81.8) | 13 (65.0) | 33 (97.1) | |
Negative | 4 (18.2) | 7 (35.0) | 1 (2.9) | |
MDR | 3 (14.3) | 2 (12.5) | 4 (10.3) | 0.90 |
Isoniazid -resistant | 4 (19.0) | 2 (12.5) | 8 (20.5) | 0.78 |
Rifampicin -resistant | 4 (19.0) | 3 (18.8) | 4 (10.3) | 0.57 |
Cough for more than 4 weeks | 33 (84.6) | 37 (92.5) | 50 (94.3) | 0.26 |
Hemoptysis | 15 (38.5) | 17 (42.5) | 23 (43.4) | 0.89 |
Fever | 21 (53.8) | 18 (45.0) | 22 (41.5) | 0.50 |
Dyspnea | 29 (74.4) | 27 (67.5) | 30 (56.6) | 0.20 |
Night sweats | 20 (51.3) | 22 (55.0) | 33 (62.3) | 0.56 |
No appetite | 23 (59.0) | 26 (65.0) | 31 (58.5) | 0.79 |
Lost weight | 28 (71.8) | 29 (72.5) | 40 (75.5) | 0.91 |
Fatigue | 30 (76.9) | 29 (72.5) | 44 (83.0) | 0.47 |
Polyuria | 15 (38.5) | 13 (32.5) | 23 (43.4) | 0.57 |
Polydipsia | 16 (41.0) | 21 (52.5) | 26 (49.1) | 0.58 |